SG
MRTX

Societe Generale’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Societe Generale’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		$99K Buy
+18,049
New +$99K ﹤0.01% 2049